Hypoxia-Inducible Transgelin-2 Confers Treatment Resistance through Activation of PI3K/Akt/GSK3β Pathway in Glioblastoma
Year: 2023
Type: article
Authors: A. Kumar, P. Rajasekera, V. Becker, S. Biehn, B. Pérez-Soto, S. Beyer, J. McElroy, A. Becker, B. Johnson, T. Cui, E. Sebastian, A. Grosu, S. Lindert, E.H. Bell, H. Manring, J. Haque, A. Chakravarti
Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, The Ohio State University Wexner Medical Center, City Of Hope National Medical Center, Deutsches Konsortium für Translationale Krebsforschung
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4387206434
